CytoMed Therapeutics Limited (GDTC) - Uzoq muddatli qarzning kapitalga nisbati

CytoMed Therapeutics Ltd (GDTC) korporativ emblemasi va logotipi

CytoMed Therapeutics (GDTC) kompaniyasining ichak va jigar o'smalarini davolovchi klinikalari bilan hamkorligi o'sish potentsialini yaratadi, bu esa uzoq muddatli qarzdorlikning kapitalga nisbati dinamikasida aks etgan. Ushbu qiymat 0.07 darajasida mustahkamlanib, Singapurda joylashgan B2B NK-terapiya ishlab chiquvchisining rivojlanishini muvozanatga soladi. Kuchli patentlar va gamma-delta T-hujayra usullarining murakkabligi ushbu innovatsion biznesni yangi kiruvchilardan ishonchli tarzda himoya qiladi.

w2.cytomed.sg - GDTC Uzoq muddatli qarzning kapitalga nisbati (davr: 21.02.2024 - 29.10.2026)

CytoMed Therapeutics kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari CytoMed|GDTC - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi CytoMed Therapeutics Limited|GDTC - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga xususiy kapital CytoMed Therapeutics|GDTC - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati w2.cytomed.sg|GDTC - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati CytoMed Therapeutics|GDTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati CytoMed|GDTC - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati CytoMed Therapeutics Limited|GDTC - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari CytoMed Therapeutics|Tezkor likvidlik koeffitsiyenti w2.cytomed.sg
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
GDTC - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:w2.cytomed.sg - GDTC
CytoMed Therapeutics original mahsuloti

Hissiy aktivlarning ishonchliligini baholash moliyalashtirish tuzilmasining barqarorligini tahlil qilishdan boshlanadi. Ushbu koeffitsient uzoq muddatli majburiyatlarni kapitalga solishtirib, biznesning tashqi qarzlarga bog'liqligini o'lchaydi. CytoMed Therapeutics (GDTC) uchun o'zining noyob T-hujayrali vaksinalarini tijoratlashtirishdan oldin qarz yuklamasining past bo'lishi juda muhimdir. Kreditlarni minimallashtirish kompaniyaga platformani monetizatsiya qilishda narxlarni belgilash imkoniyatini saqlab qolishga yordam beradi. Uzoq muddatli qarzning kapitalga nisbatini muntazam monitoring qilish emitentning moliyaviy mustaqilligini tasdiqlaydi.

Muhim raqobatchilar

Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AURA (Aura Biosciences)|CADL (candeltx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ARAY (Accuray Inc.)|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACTU: Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR - Uzoq muddatli qarzning kapitalga nisbati|tuhurabio.com (HURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protara Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio WHWK|Uzoq muddatli qarzning kapitalga nisbati TCRX|Uzoq muddatli qarzning o'z kapitaliga nisbati championsoncology.com CSBR|XBiotech - Uzoq muddatli qarzning o'z kapitaliga nisbati|CEL-SCI Corp. (CVM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|OSTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Radiopharm Theranostics Ltd - Uzoq muddatli kreditlarning kapitalga nisbati|artivabio.com (ARTV) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Adlai Nortye (ANL)|Uzoq muddatli qarzning o'z kapitaliga nisbati Veru|Uzoq muddatli qarzning o'z kapitaliga nisbati Tempest Therapeutics Inc (TPST)|Uzoq muddatli qarzning kapitalga nisbati XLO|RENB - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati MURA (Mural Oncology)|KAPA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|OKUR: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THAR: Uzoq muddatli kreditlarning kapitalga nisbati|ADVB (Advanced Biomed Inc.) - Uzoq muddatli qarzning kapitalga nisbati|GNPX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CLDI|SBFM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenetic Biosciences, Inc. XBIO|Uzoq muddatli qarzning kapitalga koeffitsiyenti SLRX|Purple Biotech - Uzoq muddatli qarzning kapitalga nisbati|AONC - Uzoq muddatli qarzning kapitalga nisbati|BeiGene (BGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CKPT (Checkpoint Therapeutics Inc.)|ELEV (Elevation Oncology, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati iCAD Corp ICAD|Uzoq muddatli qarzning o'z kapitaliga nisbati IKNA (Ikena Oncology, Inc.)|Uzoq muddatli qarzning kapitalga nisbati notablelabs.com (NTBL)|Viracta Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati MOR (MorphoSys Inc)|NAYA Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Ascentage AAPGV